Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
31
Drink up, coffee lovers. Not only is coffee aromatic and delicious, it's good for you. Who says? None other than Harvard Medical School. Once considered questionable for your health, it turns out that the beloved beverage is actually healthful in moderation. That means a few cups a day.
26
Does it make sense to offer cancer screenings to older adults? Experts' opinions vary. The Tribune asked several leading organizations to describe their policies for people considered to be low risk, without symptoms of potential illness.
22
Cancer patients don't have time to waste, yet many must endure a tedious process of elimination as physicians try several different treatments until identifying the one that is most effective against their particular type of tumor. Now researchers at the University of Virginia Health System have developed a breakthrough method that could one day eliminate this trial and error approach to treating many cancers.
People who suffer from debilitating neuropathic pain may get more relief and sleep better by combining two commonly-prescribed drugs. A new, federally-funded study by Queen's University researchers has found that taking the drugs together is a more effective treatment than taking either of them individually.
21
British medical scientists say they've demonstrated that unusual metal compounds can be used to form effective cancer drugs. Researchers at the University of Leeds and the University of Warwick said such metals can form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs.
19
The U.S. Food and Drug Administration (FDA) on Monday approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women age 10 to 25.
16
GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX(R) [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).
15
According to recent research from the United States, A majority of women with ovarian cancer will face recurrent disease despite receiving aggressive chemotherapy at the time of diagnosis. Given the complex medical and psychosocial needs of women with ovarian cancer and the time constraints within busy clinical settings, providing women with the necessary education related to their disease and treatments can be challenging.
A new study, 'Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial,' is now available. In advanced ovarian cancer, maximal efforts have to be attemptedto achieve optimal cytoreduction, as this represents the keystone in the therapeutic management.
14
In honor of National Breast Cancer Awareness Month, a group of women known as the BRAC (Be Ready Against Cancer) Pack has stepped up its efforts to encourage genetic testing for breast and ovarian cancer. The women are advocates for BRACAnalysis, a lab test that looks for mutations on the BRCA1 and BRCA2 genes, which are associated with an increased risk of breast and ovarian cancer.
We care about your feedback. Let us know how we can improve your CancerCompass experience.